Allianz Asset Management
CBAY

Allianz Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Allianz Asset Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-69,890
Closed -$358K – 2877
2019
Q3 		$358K Sell
69,890
-114,647
-62% -$694K ﹤0.01% 2476
2019
Q2 		$1.32M Buy
184,537
+1,370
+0.7% +$15.5K ﹤0.01% 2041
2019
Q1 		$2.43M Sell
183,167
-13,505
-7% -$144K ﹤0.01% 1776
2018
Q4 		$1.55M Sell
196,672
-13,311
-6% -$127K ﹤0.01% 1858
2018
Q3 		$2.33M Buy
209,983
+19,238
+10% +$239K ﹤0.01% 1879
2018
Q2 		$2.56M Buy
190,745
+63,787
+50% +$798K ﹤0.01% 1833
2018
Q1 		$1.65M Buy
126,958
+7,949
+7% +$98.8K ﹤0.01% 2011
2017
Q4 		$1.09M Buy
+119,009
New +$1.02M ﹤0.01% 2214

Other funds holding CBAY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return